Drug Delivery Program

About NVIGEN

NVIGEN is a private, nanotechnology-focused biotech company developing a suite of products and assays centered on its patented MagVigen™ and related nanoparticle platforms. Its core business model spans Diagnostics and Platform tools, offering research-use products like magnetic beads for sample preparation while advancing its NVIGEN X® liquid biopsy assay toward clinical development for cancer recurrence prediction and therapy guidance. The company is in an Early Revenue stage, commercializing research kits and services while investing in its clinical pipeline, which is currently in the Pre-clinical/development phase.

About Actipulse Neuroscience

Actipulse Neuroscience is a clinical-stage neurotech company developing novel non-invasive brain stimulation devices for central nervous system disorders. Backed by Y Combinator and operating as a Paris Brain Institute company, it leverages a proprietary platform of high-frequency magnetic pulse technology. Its lead program for Major Depressive Disorder is in Phase 3, with a preclinical pipeline targeting oncology and other CNS conditions. The company aims to become the gold standard in neuromodulation within five years.

Therapeutic Areas

Other Oncology Drugs